Affiliation:
1. Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, VLM Road, Vile Parle (w), Mumbai-400056, India
Abstract
Abstracts:
Anxiety disorder is one of the most prevalent psychiatric disorders. The high prevalence of comorbid gastrointestinal disorders and anxiety, as well as various limitations in current therapy, have necessitated the search for alternative techniques. The Gut-Brain Axis is the connecting link between the gut and the brain. One of the reasons for the Gut-Brain Axis malfunction resulting in HPA axis stimulation and anxiety is intestinal barrier dysfunction. Gut microorganisms, lipopoly-saccharides, and other factors can stimulate the disruption of this intestinal barrier. Tight junction proteins, the epithelial barrier, the mucosal membrane, the Toll-like receptor/Myeloid differentia-tion factor 88 pathway, the activated immune system, and the HPA axis could all be potential tar-gets for anxiety caused by intestinal barrier disruption. Quercetin and Rebamipide, Berberine and Agomelatine, Angiotensin II receptor type 1 blockers, and Lubiprostone can act on these targets to provide an anxiolytic effect.
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Reference107 articles.
1. Sartori S.B.; Landgraf R.; Singewald N.; The clinical implications of mouse models of enhanced anxiety. Future Neurol 2011,6(4),531-571
2. Gelfuso É.A.; Rosa D.S.; Fachin A.L.; Mortari M.R.; Cunha A.O.; Beleboni R.O.; Anxiety: a systematic review of neurobiology, traditional pharmaceuticals and novel alternatives from medicinal plants. CNS Neurol Disord Drug Targets 2014,13(1),150-165
3. Bandelow B.; Michaelis S.; Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 2015,17(3),327-335
4. Adwas A.A.; Jbireal J.M.; Azab A.E.; Anxiety: Insights into signs, symptoms, etiology, pathophysiology, and treatment. East African Scholars Journal of Medical Sciences 2019,2(October),80-91
5. Javitt DC; Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 2004,9(11),984-997, 979
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献